BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26958937)

  • 1. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53.
    Qiao C; Lu N; Zhou Y; Ni T; Dai Y; Li Z; Guo Q; Wei L
    Oncotarget; 2016 Mar; 7(13):17009-20. PubMed ID: 26958937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells.
    Qiao C; Wei L; Dai Q; Zhou Y; Yin Q; Li Z; Xiao Y; Guo Q; Lu N
    J Cell Physiol; 2015 May; 230(5):1054-63. PubMed ID: 25251374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
    Liu W; Mu R; Nie FF; Yang Y; Wang J; Dai QS; Lu N; Qi Q; Rong JJ; Hu R; Wang XT; You QD; Guo QL
    Cancer Lett; 2009 Nov; 284(2):198-207. PubMed ID: 19473757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors.
    Hu R; Chen N; Yao J; Zhao Q; Zhang F; Li ZY; You QD; Guo QL
    Anticancer Drugs; 2012 Jul; 23(6):651-8. PubMed ID: 22526619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo.
    Li HN; Nie FF; Liu W; Dai QS; Lu N; Qi Q; Li ZY; You QD; Guo QL
    Toxicology; 2009 Mar; 257(1-2):80-5. PubMed ID: 19135124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells.
    Mu R; Qi Q; Gu H; Wang J; Yang Y; Rong J; Liu W; Lu N; You Q; Guo Q
    Mol Carcinog; 2009 Dec; 48(12):1159-69. PubMed ID: 19626645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells.
    Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q
    Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
    Kim EJ; Kim GT; Kim BM; Lim EG; Kim SY; Kim YM
    BMC Complement Altern Med; 2017 Apr; 17(1):236. PubMed ID: 28454566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
    Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
    Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
    Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galangin induces human colon cancer cell death via the mitochondrial dysfunction and caspase-dependent pathway.
    Ha TK; Kim ME; Yoon JH; Bae SJ; Yeom J; Lee JS
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1047-54. PubMed ID: 23925650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells.
    Méndez-Callejas GM; Leone S; Tanzarella C; Antoccia A
    Cell Biol Int; 2014 Mar; 38(3):296-308. PubMed ID: 24155061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II.
    Wei L; Dai Q; Zhou Y; Zou M; Li Z; Lu N; Guo Q
    Biochim Biophys Acta; 2013 Jun; 1830(6):3835-45. PubMed ID: 23500080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway.
    Ha J; Zhao L; Zhao Q; Yao J; Zhu BB; Lu N; Ke X; Yang HY; Li Z; You QD; Guo QL
    Biochem Cell Biol; 2012 Aug; 90(4):521-31. PubMed ID: 22607196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diallyl trisulfide induces apoptosis of human basal cell carcinoma cells via endoplasmic reticulum stress and the mitochondrial pathway.
    Wang HC; Hsieh SC; Yang JH; Lin SY; Sheen LY
    Nutr Cancer; 2012; 64(5):770-80. PubMed ID: 22519436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer.
    Ahn BY; Trinh DL; Zajchowski LD; Lee B; Elwi AN; Kim SW
    Oncogene; 2010 Feb; 29(8):1155-66. PubMed ID: 19935715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
    Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
    Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
    Lu Z; Lu N; Li C; Li F; Zhao K; Lin B; Guo Q
    Toxicol Lett; 2012 Mar; 209(3):211-20. PubMed ID: 22245252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
    Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
    J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.